Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
03/2003
03/20/2003US20030055252 Process for producing 2-substituted thiopyrimidine-4-carboxylate
03/20/2003US20030055249 Synthesis and methods of use of pyrimidine analogues and derivatives
03/20/2003US20030055247 Thiazolyl(pyridyl)ethyne compounds
03/20/2003US20030055093 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction
03/20/2003US20030055064 Piperazine compounds and medicinal use thereof
03/20/2003US20030055054 CXCR3 antagonists
03/20/2003US20030055053 For therapy of bacterial and protozoal infections in mammals
03/20/2003US20030055049 For therapy of abnormal cell growth, such as cancer, in mammals
03/20/2003US20030055044 Administering pyrazole derivative for inhibiting GSK-3 or Aurora activity in a patient
03/20/2003US20030055025 For therapy of bacterial infections and neoplasms,
03/20/2003US20030054298 Color photography; bleaching, fixing, development
03/20/2003US20030054028 Sustained releasing drug in situ
03/20/2003US20030052310 Perfluorinated amide salts and their uses as ionic conducting materials
03/20/2003CA2459364A1 Ccr-3 receptor antagonists v
03/19/2003EP1292606A2 Positively-charged peptide nucleic acid analogs with improved properties
03/19/2003EP1292594A1 Quinazoline derivatives for the treatment of tumours
03/19/2003EP1292591A2 Substituted bicyclic derivatives for the treatment of abnormal cell growth
03/19/2003EP1177195B1 1-AMINO TRIAZOLO 4,3-a! QUINAZOLINE-5-ONES AND OR -5-THIONES INHIBITING PHOSPHODIESTERASE IV
03/19/2003EP1155002A4 Method of synthesizing barbituric acid derivatives and their use for the synthesis of chemical libraries
03/19/2003CN1404480A Pyrimidine carboxamides useful as inhibitors of PDE4 isozymes
03/19/2003CN1403446A Catalytic synthesis process of methyl substituted pyrimidyl urea derivative
03/19/2003CN1103336C Process for producing unsymmetrical 4,6-bis (aryloxy) pyrimidine compound
03/18/2003US6534522 Subtype-selective NMDA receptor ligands and the use thereof
03/18/2003US6534511 The use of certain 6-arylpyrazolo(3,4-d)pyrimidin-4-ones, 2 arylquinazolin-4-ones, 2-arylpurin-6-ones and 2-arylpyrido(3,2- d)pyrimidin-4-ones, or a pharmaceutically acceptable salt thereof, forsexual disorders
03/18/2003US6534493 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
03/18/2003US6534492 Uracil substituted phenyl sulfamoyl carboxamides
03/18/2003US6534447 Herbicidal pyridine compounds
03/18/2003CA2236239C Quinoline and quinazoline compounds useful in therapy
03/13/2003WO2003020748A1 Anti-cancer cyclopenta[g]quinazoline compounds
03/13/2003WO2003020706A1 PROCESS FOR THE PREPARATION OF CYCLOPENTA[g]QUINAZOLINE DERIVATIVES
03/13/2003WO2003020696A1 C2-substituted indane-1-ols and their derivatives, method for their production and their use as medicaments
03/13/2003WO2003020677A2 C2-substituted indane-1-ones and their derivatives, method for their production and their use as medicaments
03/13/2003WO2003020280A2 Compositions and use thereof in the treatment of cancer
03/13/2003WO2003020278A1 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases
03/13/2003WO2002096901A3 1,3-dihydroxybenzene derivatives and colorants containing said compounds
03/13/2003WO2002078625A3 Therapeutic combinations for cardiovascular and inflammatory indications
03/13/2003WO2002024194A3 Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent
03/13/2003WO2002022563A1 Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient
03/13/2003WO2002020017A3 Use of ectoin or ectoin derivatives for stabilizing p53
03/13/2003US20030050314 Treating bone disorder caused by osteoclasts, tumor growth and tumor metastasis, prophylaxis of cardiovascular disorders, nephropathies or retinopathies
03/13/2003US20030050313 One-pot reaction for making tyrosine kinase inhibitors
03/13/2003US20030050301 A drug mixture additionally comprising an antihypertensive agent or it's prodrug and a carrier, vehicle or diluent
03/13/2003US20030050250 Administering an aromatic dipeptide derivative with a chemotherapeutic agent to treat tumor metastasis, solid tumor growth, angiogenesis and other neoplasia diseases
03/13/2003US20030047439 C-nitrosoaniline compounds and their blends as polymerization inhibitors
03/13/2003CA2459584A1 Compositions and use thereof in the treatment of cancer
03/13/2003CA2458527A1 C2-substituted indane-1-ols and their derivatives, method for their production and their use as medicaments
03/13/2003CA2422135A1 Urea derivatives and adhesion molecule inhibitors containing the same as effective ingredients
03/12/2003EP1291346A1 Process for the preparation of trisubstituted imidazole compounds with multiple therapeutic properties
03/12/2003EP1289982A1 Bioisosteric benzamide derivatives and their use as apob-100 secretion inhibitors
03/12/2003EP1289968A1 Cyclic urea compounds and preparation thereof
03/12/2003EP1289965A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
03/12/2003EP1289964A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
03/12/2003EP1289963A1 Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines
03/12/2003EP1289959A1 Dihydrostilbene alkanoic acid derivatives useful as vitronectin antagonists
03/12/2003EP1289958A2 BENZOPHENONES AS INHIBITORS OF IL-1$g(b) AND TNF-$g(a)
03/12/2003EP1289944A2 Thioketals and thioethers for inhibiting the expression of vcam-1
03/12/2003EP1036058B1 Adamantane derivatives
03/12/2003EP1012144B1 Method for producing (hetero)aromatic hydroxylamines
03/12/2003EP0672031B1 Catechol diethers as selective pde iv inhibitors
03/12/2003CN1402730A Thiazolo (4,5-D) pyrimidine compounds
03/12/2003CN1401634A 4-guanidinobenzamides antifertility compounds
03/12/2003CN1401621A Intermediate for preparing tricyclic compound and preparing method thereof
03/11/2003US6531610 Intermediate acylating carbonate
03/11/2003US6531600 Treatment and compounds
03/11/2003US6531597 Reacting a halo substituted benzene with a ketone to form a hydroxyalkyl benzene that is carbonylated with a strong acid
03/11/2003US6531241 Anions of equal number to cations to maintain charge neutrality, are disclosed. These spacer groups may be organic or inorganic in origin and may vary in length. The spacer groups may be saturated, containing single bonds, or may have
03/06/2003WO2003019697A2 Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives
03/06/2003WO2003019289A1 Fluorescent dyes
03/06/2003WO2003018551A1 New mandelic acid derivatives and their use as thrombin inhibitors
03/06/2003WO2003017955A1 Oxidation hair dyes containing 3-aminophenol derivatives, and novel 3-aminophenol derivatives
03/06/2003WO2003017765A1 Treatment for cystic fibrosis
03/06/2003WO2003017764A1 Substituted propargylamines
03/06/2003WO2002096367A3 Targeted multivalent macromolecules
03/06/2003WO2002083662A3 Azo compounds and process of producing the same and novel intermediate compounds used in the process of producing azo compounds
03/06/2003WO2002066443A3 2-thioxo-1,2,3,4-tetrahydropyrimidine derivatives
03/06/2003WO2002055507A8 1-dimercaptoalkylquinazolin-2,4(1h,3h)-diones as matrix metalloproteinase (mmp) inhibitors
03/06/2003WO2002034726A9 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
03/06/2003US20030045727 Process for preparing optically active secondary alcohols having nitrogenous or oxygenic functional groups
03/06/2003US20030045718 Crystalline salts of 7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3r,5s)-3,5-dihydroxyhept-6-enoic acid
03/06/2003US20030045525 Particularly in the treatment of benign prostatic hyperplasia.
03/05/2003EP1288205A1 Novel phenylalanine derivatives
03/05/2003EP1287018A2 Thrombin inhibitors
03/05/2003EP1286997A1 6-phenylpyrrolopyrimidinedione derivatives
03/05/2003EP1286973A2 Novel carbamates and carbamides, production and use thereof as endothelin receptor antagonists
03/05/2003EP1286972A1 Pyrimidine compounds
03/05/2003EP1286971A1 (e)-7[4-(4-fluorophenyl)-6-isopropyl-2-mesylaminopyrimidin-5-yl]-(3r,5s)-dihydroxyhept-6-enoic acid
03/05/2003EP1286968A2 Substituted iminoazines
03/05/2003EP1286955A1 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides
03/05/2003EP0964865B1 Pharmaceutically active tricyclic amines
03/05/2003EP0912526B1 Antiviral 2,4-pyrimidinedione derivatives and process for the preparation thereof
03/05/2003CN1400969A Fused imidazolium derivatives
03/05/2003CN1400279A 液晶混合物 Liquid crystal mixtures
03/05/2003CN1102596C 5H-thiazole [3,2-a] pyrmidine derivatives
03/05/2003CN1102581C Process for preparing (E)-methyl 2-[2-(6-(2-cyanophenoxy)-pyrimidin-4-yloxy)phenyl]-3methoxypropenoate
03/05/2003CN1102580C Arylethenesulfonamide derivatives and drug composition containing the same
03/04/2003US6528661 Providing atorvastatin ester derivative; converting the atorvastatin ester derivative to atorvastatin hemi-calcium with calcium hydroxide
03/04/2003US6528655 Aromatic derivatives with HIV integrase inhibitory properties
03/04/2003US6528543 Glucokinase activating for treating type II diabetes; acylurea compound, phenylacetyl-substituted; 1-(2-(3-chloro-phenyl)-3cyclopentyl-propionyl)-3-methyl-urea
03/04/2003US6528514 Pyrimidin-4-one-5-amino-3-alkylcarboxamidomethyl compounds
03/04/2003US6528513 Viricides; especially cytomegalo virus
1 ... 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 ... 427